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Introduction
Chronic hypertrophic rhinitis is a common problem in 
childhood and adolescence and has a negative impact on 
both physical, social and psychological well-being [1]. The 
prevalence of  chronic hypertrophic rhinitis in children 
(CHRC) is 20-55%, and in the last 5 years this index is in-
creasing. Epidemiological data on chronic hypertrophic rhi-
nitis estimate that more than 200 million people worldwide 
suffer from it.  In the pediatric population, they showed a 
prevalence of 16.1% by the age of 5 years and a prevalence 
of 42.3 % by the age of 14 [2]. The term ”chronic rhinitis, 
hypertrophic” defines a state of congestion of the mucous 
membrane  and underlying tissues  of the  nasal concha so 
that it reduces considerably inferior nasal airway with  the 
functional consequence of constant nasal obstruction [3].
Although chronic hypertrophic rhinitis in children 
(CHRC) is a fairly common  nosological entity in children, 
its symptoms are often subtle and nonspecific and this can 
lead to overlooking the diagnosis [4]. Usually the diagno-
sis of  chronic hypertrophic rhinitis in children is based on 
symptoms that evolve for more than three months and some 
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Abstract
Background: Chronic hypertrophic rhinitis  is a common problem in childhood and adolescence and has a negative impact on both physical, social and 
psychological well-being. Chronic hypertrophic rhinitis in the prevalence of children is 20-55%, and in the last 5 years this index is increasing.
Material and methods: The study included 65 patients, aged 5 to 18 years, being hospitalized in the ENT department of the Emilian Cotaga Clinic of the 
Institute of Mother and Child, Chisinau, diagnosed with rhinitis complicated chronic hypertrophic over the years January 2018 – December 2020. The 
study was conducted by retrospective analysis of complicated data from clinical observation sheets and documents accompanying the data. Treatment 
methods studied: laser coagulation, electrocoagulation, radiofrequency, mucotomy. In most cases, lasercoagulation was chosen.
Results:  Nasal permeability in children with chronic hypertrophic rhinitis is altered in most cases. The most frequently affected age groups were 10-14 
years with a rate of 61.53%, the majority being from urban living environment in 63.08%. The most representative clinical signs and symptoms according 
to this study are difficult nasal breathing in 96.93% and mouth breathing – 89.24%.  From the indicated surgical methods, laser coagulation of the nasal 
cornets was performed in 47.7% of cases. It proved to be more effective and less invasive compared to electrocoagulation performed in 44.6% of cases 
and partial mucotomy in 4.62%.
Conclusions:  From the data obtained in the study, we opted for laser coagulation of the lower nasal horns, which has a faster healing period, shorter 
postoperative complications, greater acceptability from the doctor and patient.
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imaging examination [5]. Patients with RCHC often receive 
several types of medications, decongestants, oral antibiotic 
treatments that can change the clinical presentation, especi-
ally in the early stages of the disease [6]. 
The initial management of RCHC is medical, with goals 
that include reducing inflammation, improving drainage, 
and eradicating pathogens. Drug treatment is the first line 
of approach to the treatment of chronic rhinitis. Depending 
on the type, duration and severity of symptoms, drug treat-
ment in chronic hypertrophic rhinitis may use the following 
classes of drugs:
•	 Nasal decongestants – can be used in both topical and 
oral form;
•	 H1 anti-receptor antihistamines, used in patients with 
allergic rhinitis;
•	 Intranasal or oral corticosteroids;
•	 Cromone: sodium cromoglycate and nedocromil so-
dium;
•	 Anticholinergics: ipratropium bromide;
•	 Antileukotrienes;
•	 Specific immunotherapy, used in allergic rhinitis;
•		Intramucosal	injection	of	cortisone	[7-9].	
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In case of inefficiency of drug treatment, surgical treat-
ment is considered [8, 9].  Surgical treatment is reserved for 
cases where the correct and complete medication performed 
during 3 consecutive months is ineffective or in irreducible 
hypertrophy of the nasal cones, when surgical treatment is 
applied as a first-line method [10].
The specialty literature describes multiple surgical te-
chniques to reduce the size of the nasal cones, the choice 
which depends on several factors: the type of hypertrophy, 
the experience and habit of the surgeon, the technical equi-
pment of the clinic where the surgery is performed and, 
last but not least, the costs of intervention [11]. In case of 
reducible nasal corneal hypertrophy, several techniques are 
available, such as lateralization of the nasal cornet with or 
without submucosal vasotomy, mucotomy (partial, total, 
submucosal, anterior), electrocautery, diathermic coagulati-
on, radiofrequency coagulation, vaporization or / and laser 
coagulation [10, 11].
A simple method of restoring nasal permeability is to 
lateralize the cornets. The procedure consists of fracturing 
and lateral mobilization of the lower nasal cornet in a con-
trolled manner using a blunt instrument. The technique is 
often used in combination with other procedures. The tech-
nology is quite safe and easy to use, however in pronounced 
irreducible hypertrophy, it may not be sufficient [1].
Cauterization of the nasal horns by radiofrequency is 
another method of treatment of chronic hypertrophic rhi-
nitis. It provides for the use of high frequency energy, with 
the aim of coagulating the tissues and thus reducing the 
volume of the cornet and reducing nasal obstruction. The 
radio frequency is generated by a specially designed devi-
ce. The electric current is transmitted through an electrode 
to the tissues producing energy release, evaporation of cell 
fluid, which results in tissue coagulation and narrowing of 
the nasal cones.
The maximum effect occurs 7-14 days after the proce-
dure. The technique has a number of advantages, namely: 
it eliminates the risk of bleeding and thus the need for na-
sal tamponade, excludes the need for general anesthesia in 
adults, so the method falls within the requirements of ex 
officio surgery [12, 13].
Microdebrider mucotomy is a beneficial alternative in 
chronic hypertrophic rhinitis because it has the advantage 
of reducing the hypertrophied and hyperplastic tissue of the 
lower cornet under direct visualization, without bone lesi-
ons and without deep thermal effect [14].
The mucotomy technique with the microdebrider can be 
done with local anesthesia, by infiltration, or with general 
anesthesia, depending on the size of the nasal cornet hyper-
trophy, the existing comorbidities, but also the patient’s wis-
hes. The entire tissue of the hypertrophied cornet is resected 
and with predilection of the posterior third and the tail of 
the inferior nasal cornet, which are then aspirated on the 
aspiration system of the apparatus. The results of cornet 
surgery with the microdebrider prove to be very good, with 
favorable long-term functional results [2, 14].
Electrocoagulation was the first method recorded for the 
RCHC treatment and has constantly evolved in its practice. 
This method consists in decreasing the size of the inferior 
nasal cone by cauterization due to the volumetric reduction 
of the nasal cone due to the retraction following the hea-
ling process that follows. The technique can be performed 
by local anesthesia (adults only) or general, under direct 
endoscopic visualization and usually requires nasal tampo-
nade [14]. The long-term results of this technique are con-
troversial because the recurrence rate of cornet hypertrophy 
is high [6, 10].
Cornetotomy or partial cornetectomy is performed in 
advanced hypertrophies of the nasal cornet when hyper-
plastic changes of connective tissue and turbine bone occur. 
Cornetotomies are performed submucosally by creating two 
flaps: medial and lateral, and removing excess connective 
and bone tissue. It is indicated in the hypertrophy of the 
head and body of the nasal cornet, less often in the muriform 
hypertrophy of the cornet tail. If done technically correctly, 
there is practically no open area of the wound and a signifi-
cant volumetric reduction of the nasal cone is obtained. The 
procedure has been applied in several studies, which have 
shown a lasting positive effect on nasal breathing [4, 11, 15].
Regarding the extensive resections of nasal cones, it sho-
uld be mentioned that at present they belong to the field 
of the past, having a predominantly historical interest, due 
to various complications – atrophic rhinitis, ”empty nose” 
syndrome, which has generated new scientific research and 
research to make the surgical approach much more cost-
effective. Thus, the concept of minimally invasive endonasal 
surgery was developed, which provides for the maximum 
preservation of the pituitary mucosa – the noble element 
of the nasal fossae [15-17]. Minimally invasive surgery in-
volves surgical maneuvers, which are related to the limited 
ablation of pathological tissues with the maximum possible 
respect for healthy skin and surrounding tissues. This type 
of surgery has clearly superior advantages over radical sur-
gery, because the repair processes are evolving much more 
favorably, in connection with the considerable reduction of 
surgical trauma.
Material and methods
The study included 65 patients, aged 5 to 18 years, being 
hospitalized in the ENT department of the Emilian Cotaga 
Clinic with the diagnosis of chronic hypertrophic rhini-
tis, during January 2018 – December 2020. This study was 
achieved through retrospective analysis of complicated data 
from clinical observation sheets and  documents accom-
panying the data.
Laser coagulation of the nasal horns
Several types of lasers are known, but in nasal cornet sur-
gery the most common are the Diode laser, the Potassium-
Titanium-Phosphate (KTP) laser and the CO2 laser. In the 
first two types, the conduction of the laser beam is perfor-
med through fiber and direct contact with the tissues of the 
nasal horns, which is an advantage. Another difference be-
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tween the first types and the CO2 laser is the wavelength of 
the emitted light and its ability to penetrate deep. The effect 
of the wave is strictly on the mucosa of the lower nasal cor-
net, the laser having no effect on the skeleton.
In the case of diode laser intervention (fig. 1), the volu-
me of the lower nasal cone decreases by the retraction of the 
loose tissue secondary to the thermal lesions of the tissues. 
The CO2 laser produces necrotic debris and fibroepithelial 
reshaping, which replace the vaporized mucosa [18].
The application of choice is the submucosal one, and the 
important condition is the use of the endoscopic technique 
(fig. 2). The advantage of this technique is the absence of 
bleeding of the operative field and the need for nasal tampo-
nade, minimal damage to the mucosal surface of the nasal 
cone, low reduction of possible disturbance of mucociliary 
clearance and the possibility of bleeding and scarring in the 
postoperative period. The operation in adults can be perfor-
med under local anesthesia.
Results and discussion
A number of risk factors were analyzed that could lead 
to the development of chronic hypertrophic rhinitis and to 
the worsening of the evolution of the subsequent diagnosis. 
One of the main factors is the distribution according to 
the age of the patients, thus there was a higher addressing of 
patients aged 10-14 years with a rate of 61.53%, followed by 
those aged 5-9 years with a rate of 24.62%, then being fol-
lowed by those aged 15-18 with a rate of 13.85%. The results 
are shown in fig. 5.
 
 
Fig. 5.  Distribution of patients by age groups
 Among the social factors that can influence the evolu-
tion of RCHC is the living environment of patients. Thus, 
according to figure 6, the number of patients is higher in the 
urban living environment – 41 cases, with an incidence rate 
of 63.08%, and in the rural living environment – 24 cases 
with a rate of 36.92%.
Fig. 1 .  Diode Laser (Medilas D LiteBeam +)
Fig. 2.  Laser application techniques in chronic hypertrophic rhinitis in children (CHRC)
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Fig. 6.  Distribution of the number of cases depending  
on the living environment 
Based on the data obtained from the study on a group 
of 65 patients, it is observed according to fig. 7, the main 
symptoms were: difficult nasal breathing in 96.93% and mo-
uth breathing – 89.24%. Other symptoms presented were: 
nasal voice in 83.08%, fatigue in 78.47%, snoring in 70.77%, 
sero-mucous secretions in 66.16%, hyposmia in 49.24% and 
headache in 32.31% cases.
Fig. 7. Distribution of data depending on the symptoms 
presented
 
From the multitude of methods listed in chronic hyper-
trophic rhinitis in children (CHRC) surgery, in 31 cases, la-
ser coagulation with a rate of 47.7% was chosen. The diode 
laser was used under general anesthesia, according to the 
method developed in the clinic, aseptic conditions were ob-
served.  Electrocoagulation applied in 29 cases at a rate of 
44.62%, and 3 cases – 4.62% for the partial mucotomy, and 
in other two cases –  3.06 % another method was chosen 
(fig. 8).
One of the first studies on laser reduction of hyper-
plastic lower nasal turbinates were performed by Lenz et 
al., who treated over 2000 patients with nasal obstruction 
due to vasomotor rhinitis [18]. In 80% of patients there was 
an improvement in nasal breathing and a completely free 
breathing after a period of about 10 years. Similar results 
were demonstrated by Levine HL. in a trial using laser coa-
gulation in 29 patients suffering from allergic or vasomotor 
rhinitis [1]. After a monitoring period of 6 ± 12 months, 
81% of patients described a subjective improvement in nasal 
breathing, less nasal congestion [19]. 
Reduction of hypertrophied nasal cornets by diode la-
ser is safe, minimally invasive and effective in relieving the 
symptoms associated with chronic hypertrophic rhinitis. To 
date, there are only a few reports in the literature on mus-
sel treatment. Min et al. treated 53 patients with diode laser 
vasomotor rhinitis (810 nm) [5]. The results on nasal ob-
struction were very satisfactory. In another investigation, 30 
patients treated endoscopically with a diode laser (940 nm) 
were able to achieve an improvement in nasal respiration 
by 85% [3]. DeRowe et al. noticed that no more than 41% 
of patients received improved postoperative nasal breathing 
[8].
Hoffmann et al. performed the laser treatment of the 
lower turbines using the continuous wave diode laser [12]. 
The laser light was applied through endonasal endoscopes 
containing a laser channel. A power of 3W was established, 
and the laser tip was slowly pulled into contact from the rear 
end to the front end of the flow turbine, producing white 
areas of coagulation (”whitening”) of tissue [19]. Additional 
treatment was performed on hyperplastic tissue in impor-
tant aerodynamic areas. Seventy-two patients were treated 
with this method, all noticing an improvement in nasal bre-
athing after six months. Side effects and complications of la-
ser surgery were not described in this study [20]. Compared 
to most of these treatment modalities, laser surgery of the 
nasal obstruction is a minimally invasive procedure with 
a controllable ablation of the hypertrophied tissue causing 
fewer complications (e.g. , bleeding, dryness, synechiae and 
pain). The application is easy to make, offering a cost-effec-
tive and time-saving method for reducing hyperplastic tur-
bines. Moreover, laser treatment appears to be as effective 
or even more effective for reducing hyperplastic turbines 
than most conventional surgical techniques, such as mu-
cotomy, electrocautery, radiofrequency [15]. More invasive 
(radical) operating methods, such as lower turbinoplasty, 
submucosal turbinectomy, lateral fracture, and partial and 
total turbinectomy have the advantage of partially removing 
large hyperplastic parts of the turbinates, leading to a reduc-
tion in obstructive tissue and better results. However, these 
methods have a higher invasiveness, a longer recovery and 
much higher costs than laser therapy [4]. Although the total 
turbinectomy produced a substantial increase in the level 
of nasal air, it also led to the destruction of the cilia, atro-
phy of the mucous membrane and chronic nasal infections, 
with a reduction in the moisturizing capacity and the nasal 
mucosa.
Submucosal diathermy was first used by Neres FE. [3] in 
1907 and developed rapidly in the following years. Beck IC. 
 led the 1930s by the unipolar method [14] and Hurd LM. 
Fig. 8.  Distribution of cases depending on the surgical  
method performed  
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introduced bipolar diathermy in 1931 [20]. The F. target 
submucosal diathermy is current-induced scarring and ob-
literation in the submucosa of the lower nasal horns. The 
results of therapy after submucosal diathermy are evalua-
ted very differently in the literature. The short-term results 
are good and exceed 80%, with a higher success of therapy 
in non-allergic patients [9]. However, if the monitoring pe- 
riod is longer, the results of the therapy are clearly worse [2]. 
A retrospective study showed that after 2 years, only 36% 
of patients treated were satisfied with the outcome of treat-
ment [19].
From the data obtained in the study, we opted for laser 
coagulation of the lower nasal horns, which has a faster hea-
ling period, shorter postoperative complications, greater ac-
ceptability from the doctor and patient.
Conclusions
Nasal permeability in children with chronic hypertro-
phic rhinitis is altered in most cases. The most frequently 
affected age groups were 10-14 years with a rate of 61.53%, 
the majority being from urban living environment – 
63.08%.  The most representative clinical signs and symp-
toms according to this study are difficult nasal breathing in 
96.93% and mouth breathing in 89.24%.
From the indicated surgical methods, laser coagulati-
on of the nasal cornets was performed in 47.7% of cases. It 
proved to be more effective and less invasive compared to 
electrocoagulation performed in 44.6% of cases and partial 
mucotomy in 4.62%.
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